Drugmaker AbbVie expects Humira volume erosion to worsen
Go back to Drugmaker AbbVie expects Humira volume erosion to worsen| AbbVie (NYSE: ABBV) | Delayed: 233.88 +3.87 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.01 | 52 Week High | $68.12 | |||
| Open | $232.97 | 52 Week Low | $50.71 | |||
| Day High | $234.71 | P/E | 50.73 | |||
| Day Low | $231.30 | EPS | $4.61 | |||
| Volume | 2,659,855 | |||||

